PB1849: TRIAL IN PROGRESS: PHASE IB/II STUDY OF SIREMADLIN IN COMBINATION WITH VENETOCLAX + AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO ARE INELIGIBLE FOR INTENSI...

por Daver, N. G., Wei, A. H., Stein, E. M., DeAngelo, D. J., Pathak, D., Xu, Y., Grzesiak, S., Venditti, A.
Publicado 2022

Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis

por Krez, A., Lane, J., Heilbronner, A., Park-Min, K.-H., Kaneko, K., Pannellini, T., Mintz, D., Hansen, D., McMahon, D.J., Kirou, K.A., Roboz, G., Desai, P., Bockman, R.S., Stein, E.M.
Publicado 2021